Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
JAMA Psychiatry
|
April 8, 2026
General Anesthesia and Discrete Components of Ketamine Neurophysiology
Ben Deverett, Duan Li, Theresa R Lii, et al.
Biological Psychiatry
|
March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J Murphy, Rachael Sumner, William Evans, et al.
Neuropharmacology
|
November 7, 2025
LSD microdosing in major depressive disorder: results from an open-label trial
Dimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 19, 2026
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a phase 2a trial
Dimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Human Brain Mapping
|
October 22, 2019
Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia
Bhim M Adhikari, Juergen Dukart, Joerg F Hipp, et al.
Pilot and Feasibility Studies
|
October 5, 2023
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, et al.
Human Microbiome Journal
|
September 6, 2021
Adjunctive dental therapies in caries-active children: Shifting the cariogenic salivary microbiome from dysbiosis towards non-cariogenic health
Claudia Lyashenko, Elisa Herrman, Jessica Irwin, et al.
Translational Psychiatry
|
February 16, 2023
Functional connectivity signatures of NMDAR dysfunction in schizophrenia-integrating findings from imaging genetics and pharmaco-fMRI
Arnim J Gaebler, Nilüfer Fakour, Felix Stöhr, et al.
Trials
|
August 24, 2024
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Linking human brain functional connectivity to underlying neurotransmission
Leon D Lotter, Golia Shafiei, Daouia Larabi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
JAMA Psychiatry
|
April 8, 2026
General Anesthesia and Discrete Components of Ketamine Neurophysiology
Ben Deverett, Duan Li, Theresa R Lii, et al.
Biological Psychiatry
|
March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J Murphy, Rachael Sumner, William Evans, et al.
Neuropharmacology
|
November 7, 2025
LSD microdosing in major depressive disorder: results from an open-label trial
Dimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 19, 2026
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a phase 2a trial
Dimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Human Brain Mapping
|
October 22, 2019
Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia
Bhim M Adhikari, Juergen Dukart, Joerg F Hipp, et al.
Pilot and Feasibility Studies
|
October 5, 2023
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, et al.
Human Microbiome Journal
|
September 6, 2021
Adjunctive dental therapies in caries-active children: Shifting the cariogenic salivary microbiome from dysbiosis towards non-cariogenic health
Claudia Lyashenko, Elisa Herrman, Jessica Irwin, et al.
Translational Psychiatry
|
February 16, 2023
Functional connectivity signatures of NMDAR dysfunction in schizophrenia-integrating findings from imaging genetics and pharmaco-fMRI
Arnim J Gaebler, Nilüfer Fakour, Felix Stöhr, et al.
Trials
|
August 24, 2024
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Linking human brain functional connectivity to underlying neurotransmission
Leon D Lotter, Golia Shafiei, Daouia Larabi, et al.
Page
of 4